Last reviewed · How we verify
Administration of Ropivacaïne — Competitive Intelligence Brief
phase 3
Local anesthetic (amide)
Voltage-gated sodium channels
Anesthesia / Pain Management
Small molecule
Live · refreshed every 30 min
Target snapshot
Administration of Ropivacaïne (Administration of Ropivacaïne) — Centre Hospitalier Departemental Vendee. Ropivacaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and conduction of nerve impulses.
Comparator set (6 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Administration of Ropivacaïne TARGET | Administration of Ropivacaïne | Centre Hospitalier Departemental Vendee | phase 3 | Local anesthetic (amide) | Voltage-gated sodium channels | |
| LIDOCAINE 1 % | LIDOCAINE 1 % | Ain Shams Maternity Hospital | marketed | Local anesthetic | Voltage-gated sodium channels | |
| Lidocaine and sodium bicarbonate | Lidocaine and sodium bicarbonate | University of Zurich | marketed | Local anesthetic | Voltage-gated sodium channels | |
| Lidoderm 5% patch | Lidoderm 5% patch | Nicole K Brogden | marketed | Local anesthetic | Voltage-gated sodium channels | |
| Mepivacaine Injection | Mepivacaine Injection | Nova Scotia Health Authority | marketed | Local anesthetic (amide) | Voltage-gated sodium channels | |
| lignocaine+bicarbonate | lignocaine+bicarbonate | Aligarh Muslim University | marketed | Local anesthetic | Voltage-gated sodium channels | |
| intravenous lidocaine (IVL) | intravenous lidocaine (IVL) | Ciusss de L'Est de l'Île de Montréal | marketed | Local anesthetic; Class IB antiarrhythmic | Voltage-gated sodium channels |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Local anesthetic (amide) class)
- Poznan University of Medical Sciences · 4 drugs in this class
- Nantes University Hospital · 3 drugs in this class
- Bozyaka Training and Research Hospital · 2 drugs in this class
- ASST Gaetano Pini-CTO · 2 drugs in this class
- Centre Hospitalier Universitaire de Nīmes · 1 drug in this class
- Chiang Mai University · 1 drug in this class
- Beijing Tiantan Hospital · 1 drug in this class
- Complejo Hospitalario Universitario de Granada · 1 drug in this class
- Ciusss de L'Est de l'Île de Montréal · 1 drug in this class
- China Medical University, China · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Administration of Ropivacaïne CI watch — RSS
- Administration of Ropivacaïne CI watch — Atom
- Administration of Ropivacaïne CI watch — JSON
- Administration of Ropivacaïne alone — RSS
- Whole Local anesthetic (amide) class — RSS
Cite this brief
Drug Landscape (2026). Administration of Ropivacaïne — Competitive Intelligence Brief. https://druglandscape.com/ci/administration-of-ropivaca-ne. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab